“Right now, we are only seeing the tip of the iceberg in opioids and breast cancer. By characterizing how opioid-induced changes in the gut microbiome impact cancer patients, we can eventually design interventions to prevent these adverse changes that may influence cancer outcome.” --- Kristin Rojas, MD